UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
Life Sciences & Biomedicine | Psychiatry | Science & Technology | United States - epidemiology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Risk | Case-Control Studies | Dose-Response Relationship, Drug | Psychotropic Drugs - adverse effects | Dibenzothiazepines - adverse effects | Risperidone - adverse effects | Female | Registries | Retrospective Studies | Dementia - drug therapy | Quetiapine Fumarate | Veterans - psychology | Psychotropic Drugs - administration & dosage | Haloperidol - adverse effects | Dementia - mortality | Antipsychotic Agents - administration & dosage | Aged | Benzodiazepines - adverse effects | Veterans - statistics & numerical data | Antidepressive Agents - adverse effects | Dosage and administration | Antipsychotic drugs | Mortality | Analysis | Risk factors | Dementia | Veterans | Comorbidity | Americans | Survivors | Outpatient Treatment | Longitudinal Study | Psychiatric Disorders | Epidemiology | Benzodiazepines | Conventional Antipsychotics | Anticonvulsants | Cognitive Disorders | Etiology | Psychopharmacology | Opioids | Aging | Antidepressant Drugs | Atypical Antipsychotics | PTSD (ICD-9) | Negative Therapeutic Reaction | Index Medicus | Abridged Index Medicus
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2009, Volume 15, Issue 22, pp. 2535 - 2549
Neuroimaging | Antipsychotics | Typical | Atypical neuroleptics | MRI | Schizophrenia | Conventional | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Brain - drug effects | Antipsychotic Agents - therapeutic use | Humans | Brain - pathology | Magnetic Resonance Imaging - methods | Clinical Trials as Topic | Schizophrenia - pathology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 06/2018, Volume 2018, Issue 6, pp. CD005594 - CD005594
Delirium | Atypical antipsychotics | Olanzapine | Pharmacological Interventions | Placebo Effect | Mental health | Hospitalization | Haloperidol | Benzodiazepines | Randomized Controlled Trials as Topic | Neurology | Antipsychotic Agents | Risperidone | Medicine General & Introductory Medical Sciences | Antipsychotic Agents - adverse effects | Humans | Haloperidol - therapeutic use | Male | Haloperidol - adverse effects | Delirium - drug therapy | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Risperidone - adverse effects | Adult | Female | Benzodiazepines - adverse effects | Delirium - mortality | Benzodiazepines - therapeutic use | Index Medicus
Journal Article
Journal of clinical psychopharmacology, ISSN 0271-0749, 06/2013, Volume 33, Issue 3, pp. 319 - 328
clozapine | smoking reduction | schizophrenia | nicotine replacement therapy | atypical antipsychotics | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Tobacco smoking | Schizophrenia | Biological and medical sciences | Medical sciences | Neuropharmacology | Psycholeptics: tranquillizer, neuroleptic | Toxicology | Psychoses | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Addictive behaviors | Tobacco, tobacco smoking | Nicotine - administration & dosage | Nicotine - therapeutic use | Humans | Middle Aged | Linear Models | Male | Smoking Cessation - methods | Smoking Prevention | Bupropion - administration & dosage | Dose-Response Relationship, Drug | Antipsychotic Agents - therapeutic use | Smoking - epidemiology | Tobacco Use Cessation Products | Adult | Female | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Bupropion - therapeutic use | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 10/2017, Volume 18, Issue 10, p. 2174
Schizophrenia | Atypical antipsychotics | Treatment resistance | Polypharmacy | Metabolic syndrome | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Neuroleptics | Mental disorders | Clozapine | Metabolism | Patients | Neurotransmitter receptors | Quality of life | Psychotropic drugs | Glucose metabolism | Side effects | Receptors | Lipid metabolism | Metabolic disorders | Index Medicus | metabolic syndrome | schizophrenia | atypical antipsychotics | polypharmacy | treatment resistance
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD008559 - CD008559
Developmental, psychosocial & learning problems | Piperazines | Atypical defiance | Aggression | Quetiapine Fumarate | Attention Deficit Disorder with Hyperactivity | Antisocial behaviour and conduct disorders | PSYCHOSOCIAL PROBLEMS | Randomized Controlled Trials as Topic | Dibenzothiazepines | Antipsychotic Agents | Anxiety Disorders | Conduct Disorder | Thiazoles | Child health | Depressive Disorder, Major | Risperidone | Weight Gain | Medicine General & Introductory Medical Sciences | Drug interventions | Developmental, psychosocial, and learning problems | Attention Deficit and Disruptive Behavior Disorders | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Conduct Disorder - drug therapy | Antipsychotic Agents - adverse effects | Humans | Child, Preschool | Piperazines - therapeutic use | Thiazoles - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Quetiapine Fumarate - therapeutic use | Attention Deficit and Disruptive Behavior Disorders - drug therapy | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Dibenzothiazepines - adverse effects | Adolescent | Risperidone - adverse effects | Anxiety Disorders - drug therapy | Aggression - drug effects | Child | Depressive Disorder, Major - drug therapy | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2013, Issue 5, pp. CD006654 - CD006654
Drugs | Costs | Olanzapine | Piperazines | Anti‐psychotics | Quetiapine Fumarate | Mental health | Amisulpride | Schizophrenia | Clozapine | Aripiprazole | Insurance medicine | Sulpiride | Benzodiazepines | Quinolones | Dibenzothiazepines | Schizophrenia & psychosis | Antipsychotic Agents | Thiazoles | General | Antipsychotic medication: atypical | Risperidone | Medicine General & Introductory Medical Sciences | Clinical care ‐ by treatment category | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clozapine - therapeutic use | Sulpiride - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Piperazines - therapeutic use | Thiazoles - therapeutic use | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Schizophrenia - drug therapy | Benzodiazepines - therapeutic use | Index Medicus
Journal Article